Skip to main content
SpringerLink
Log in
Book cover

Concise Manual of Hematology and Oncology pp 204–292Cite as

Supportive Treatment

  • Chapter

  • 2125 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. ESMO Guidelines Working Group. Chemotherapy-induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis. Ann Oncol 2007;18(suppl 2):ii83–5

    Google Scholar 

  2. Grunberg SM, Deuson RR, Mavros P et al. Incidence of chemotherapy-induced nausea and emesis after modern anti-emetics. Cancer 2004;100:2261–8

    PubMed  Google Scholar 

  3. Hesketh PJ, Kris MG, Grünberg SM et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997;15:103–9

    PubMed  CAS  Google Scholar 

  4. Jordan K, Kasper C, Schmoll HJ. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer 2005;41:199–205

    PubMed  CAS  Google Scholar 

  5. Kris MG, Heskett PJ, Somerfield MR et al. ASCO Guideline for antiemetics in oncology. J Clin Oncol 2006;24:2932–47

    PubMed  CAS  Google Scholar 

  6. Oettle H, Riess H. Treatment of chemotherapy-induced nausea and vomiting. J Cancer Res Clin Oncol 2001;127:340–5

    PubMed  CAS  Google Scholar 

  7. Schnell FM. Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. Oncologist 2003;8:187–98

    PubMed  CAS  Google Scholar 

  8. http://www.mascc.org Supportive Care in Cancer, MASCC

    Google Scholar 

  9. http://www.guideline.gov National Guideline Clearinghouse

    Google Scholar 

  10. http://www.nccn.org/professionals/
physician_gls/PDF/antiemesis.pdf NCCN Guidelines Antiemesis

    Google Scholar 

  11. http://www.nlm.nih.gov/medlineplus/
ency/article/003117.htm Medline Plus, Nausea / Vomiting

    Google Scholar 

  12. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 2004;100:228–37

    PubMed  Google Scholar 

  13. De Pauw BE. Strategies in the treatment of infections in neutropenic patients. Med Microbiol Lett 1996;5:305–9

    Google Scholar 

  14. Hughes WT, Armstrong D, Bodey GP et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–51

    PubMed  Google Scholar 

  15. Kern WV, Cometta A, De Bock R et al. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999;341:312–8

    PubMed  CAS  Google Scholar 

  16. Neuburger S, Maschmeyer G. Update on managment of infections in cancer and stem cell transplant patients. Ann Hematol 2006;85:345–56

    PubMed  Google Scholar 

  17. Pizo PA. Fever in immunocompromised patients. N Engl J Med 1999;341:893–900

    Google Scholar 

  18. Smith TJ, Khatcheressian J, Lyman GH et al. 2006 Update of recommendations for the use of white blood cell growth factors. An evidence-based clinical practice guideline. J Clin Oncol 2006;24:3187–205

    PubMed  CAS  Google Scholar 

  19. http://www.guideline.gov National Guideline Clearinghouse

    Google Scholar 

  20. http://www.mascc.org Supportive Care in Cancer, MASCC

    Google Scholar 

  21. http://www.neutropenia.ca/ Neutropenia Support Association

    Google Scholar 

  22. http://www.nccn.org/professionals/physician_gls/
PDF/myeloid_growth.pdf NCCN Guideline

    Google Scholar 

  23. Aapro MS. Cameron DA, Pettengell R et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 2006;42:2433–53

    Google Scholar 

  24. Bokemeyer M, Aapro MS, Courdia A et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007;43:258–70

    PubMed  CAS  Google Scholar 

  25. Clark OAC, Lyman GH, Castro AA et al. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomised controlled trials. J Clin Oncol 2005;23: 4198–214

    PubMed  CAS  Google Scholar 

  26. Crawford J et al. Myeloid growth factors in cancer treatment. NCCN, Clinical Practice Guidelines in Oncology - v.2.2005

    Google Scholar 

  27. ESMO Guidelines Working Group. Hematopoietic growth factors: ESMO recommendations for the application. Ann Oncol 2007;18(suppl 2):ii89–91

    Google Scholar 

  28. ESMO Guidelines Working Group. Erythropoietins in cancer patients: ESMO recommendations for use. Ann Oncol 2007;18(suppl 2):ii86–8

    Google Scholar 

  29. Rizzo JD, Somerfield MR, Hagerty KL et al. Use of epoetin and darbepoetin in patients with cancer: 2007 ASCO/ASH Clinical Practice Guideline Update. J Clin Oncol 2008;26:132–49

    PubMed  CAS  Google Scholar 

  30. Smith TJ, Khatcheressian J, Lyman GH et al. 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: an evidence-based clinical practice guideline. J Clin Oncol 2005;24:3187–205

    Google Scholar 

  31. Spielberger R, Stiff P, Bensinger W et al. Palifermin for oral mucositis after intensive therapy for hematologic cancer. N Engl J Med 2004;351:2590–8

    PubMed  CAS  Google Scholar 

  32. http://www.asco.org ASCO, Am Soc Clin Oncol

    Google Scholar 

  33. http://www.mascc.org Supportive Care in Cancer

    Google Scholar 

  34. http://www.hematology.org ASH, Am Soc Clin Oncol

    Google Scholar 

  35. http://www.esmo.org ESMO, Eur Soc Med Oncol

    Google Scholar 

  36. http://www.guideline.gov National Guideline Clearinghouse

    Google Scholar 

  37. http://wwwahrq.gov/clinic/epcix.htm Agency for Healthcare Research and Quality

    Google Scholar 

  38. Arends J, Bodoky G, Bozzetti F et. al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 2006;25:245–59

    PubMed  CAS  Google Scholar 

  39. Davis MP, Dreicer R, Walsh D et al. Appetite and cancer associated anorexia. J Clin Oncol 2004;22:1510–7

    PubMed  CAS  Google Scholar 

  40. Detsky A, Mc Laughlin J. Baker J et al. What is Subjective Global Assessment of Nutritional Status? JPEN 1987;11:8–13

    CAS  Google Scholar 

  41. Doyle C, Kushi LH, Byers T et al. Nutrition and physical activity during and after cancer treatment. CA Cancer J Clin 2006;56:323–53

    PubMed  Google Scholar 

  42. Morrison G, Hark L. Medical Nutrition and Disease. Blackwell Science, 1999

    Google Scholar 

  43. Nitenberg G, Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Hematol Oncol 2000;34:137–68

    CAS  Google Scholar 

  44. Skipworth R, Fearon KCK. The scientific rationale for otimizing nutritional support in cancer. Eur J Gastroenterol Hepatol 2007;19:371–7

    PubMed  Google Scholar 

  45. http://www.mascc.org Multinational Association of Supportive Care in Cancer

    Google Scholar 

  46. http://www.nutritioncare.org Am Soc Parental and Enteral Nutrition

    Google Scholar 

  47. http://www.nutrition.org American Society for Clinical Nutrition

    Google Scholar 

  48. http://www.cancer.org/docroot/MBC/MBC_6.asp Am Cancer Society, Nutrition

    Google Scholar 

  49. http://www.espen.org Eur Soc Clin Nutrition Metabolism

    Google Scholar 

  50. ASPEN: Board of directors. Specific guidelines for disease adults: Cancer JPEN 2002;26:82SA–83SA

    Google Scholar 

  51. ASPEN: Board of directors. Specific guidelines for disease adults: Cancer - hematopoietic cell transplantation. JPEN 2002;26:83SA–85SA

    Google Scholar 

  52. Bozetti F, Cavazzi C, Mariani L et al. Artificial nutrition in cancer patients: which route, what composition? World J Surg 1999;23:577–83

    Google Scholar 

  53. Wilson RL. Optimizing nutrition for patients with cancer. Clin J Oncol Nurs 2000;4:23–8

    PubMed  CAS  Google Scholar 

  54. http://www.mascc.org/ Multinational Association of Supportive Care in Cancer

    Google Scholar 

  55. http://cancernet.nci.nih.gov/ CancerNet, with Information on Parenteral Nutrition

    Google Scholar 

  56. http://www.nutritioncare.org/ Am Soc Parenteral Enteral Nutrition

    Google Scholar 

  57. http://www.nutrition.org/ American Society for Clinical Nutrition

    Google Scholar 

  58. Goldberg GR, Morrison RS. Pain management in hospitalized cancer patients. J Clin Oncol 2007;25:
1792–801

    PubMed  Google Scholar 

  59. Jost LM. Management of cancer pain. ESMO Clinical Recommendations. Ann Oncol 2007;18(suppl 2):ii92–4

    PubMed  Google Scholar 

  60. Levy MH, Samuel TA. Management of cancer pain. Semin Oncol 2005;32:179–93

    PubMed  Google Scholar 

  61. McNicol E, Strassels S, Goudas L et al. Nonsteroidal anti-inflammatory drugs, alone or in combination with opioids, for cancer pain: a systematic review. J Clin Oncol 2004;22:1975–92

    PubMed  CAS  Google Scholar 

  62. McQuay H. Opioids in pain management. Lancet 1999;353:2229–32

    PubMed  CAS  Google Scholar 

  63. Mercadante S. The use of anti-inflammatory drugs in cancer pain. Cancer Treat Rev 2001;27:51–61

    PubMed  CAS  Google Scholar 

  64. Van den Beuken-Van Everdingen MHJ, De Rijke JM, Kessels AG et al. Prevalence of pain in patients with cancer. Ann Oncol 2007;18:1437–49

    PubMed  Google Scholar 

  65. http:// www.dgss.org DGSS, German Assoc. for the Study of Pain

    Google Scholar 

  66. http://www.painresearch.utah.edu/cancerpain Cancer Pain Resource

    Google Scholar 

  67. http://www.ampainsoc.org APS, American Pain Society

    Google Scholar 

  68. http://www.painmed.org/ AAPM, American Academy of Pain Medicine

    Google Scholar 

  69. http://www.cancer-pain.org/ Cancer Pain Organisation

    Google Scholar 

  70. http://www.who.org WHO Pain Ladder

    Google Scholar 

  71. http://www.nccn.org Cancer Pain Guidelines

    Google Scholar 

  72. Carrol KK, Kohli S, Mustian KM et al. Pharmacologic treatment of cancer- related fatique. Oncologist 2007;12(suppl 1):43–52

    Google Scholar 

  73. Escalante CP. Treatment of cancer-related fatigue: an update. Support Care Cancer 2003;11:79–83

    PubMed  Google Scholar 

  74. Glaus A. Fatigue in Patients with Cancer. Analysis and Assessment. Springer, Berlin Heidelberg New York, 1998

    Google Scholar 

  75. Iop A, Manfredi AM, Bonura S. Fatigue in cancer patients receiving chemotherapy. Ann Oncol 2004;15:712–20

    PubMed  CAS  Google Scholar 

  76. Morrow GR, Shelke AR, Roscoe JA et al. Management of cancer-related fatigue. Cancer Invest 2005;22:229–39

    Google Scholar 

  77. Stasi R, Abriani L, Beccaglia P et al. Cancer-related fatigue. Cancer 2003;98:1786–801

    PubMed  Google Scholar 

  78. Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 2004;91:822–8

    PubMed  CAS  Google Scholar 

  79. http://www.nci.nih.gov/cancerinfo/pdq/supportivecare/ NCI PDQ, Fatigue

    Google Scholar 

  80. http://www.nccn.org/professionals/physican_gls/PDF/fatique.pdf NCCN Fatigue Guidelines

    Google Scholar 

  81. http://www.cancer.org/docroot/MIT/MIT_2_2x_Fatigue.asp ACS, Fatigue

    Google Scholar 

  82. Berenson JR, Hillner BE, Kyle RA et al. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002;20:3719–36

    PubMed  Google Scholar 

  83. Clézardin P, Ebetino FH, Fournier PGJ. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity. Cancer Res 2005;65:4971–4

    PubMed  Google Scholar 

  84. Coleman RE. Bisphosphonates in breast cancer. Ann Oncol 2005;16:687–95

    PubMed  CAS  Google Scholar 

  85. Hillner BE, Ingle JN, Chlebowski RT et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003;21:4042–57

    PubMed  CAS  Google Scholar 

  86. Lüftner D, Henschke P, Possinger K. Clinical value of bisphosphonates in cancer therapy. Anticancer Res 2007;27:1759–68

    PubMed  Google Scholar 

  87. Santini D, Vespasiani Gentilucci U, Vincenzi B et al. The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol 2003;14:1468–76

    PubMed  CAS  Google Scholar 

  88. Wu S, Dahut WL, Gulley, JL. The use of bisphosphonates in cancer patients. Acta Oncol 2007;46:581–91

    PubMed  CAS  Google Scholar 

  89. http://www.asco.org/ ASCO Guidelines

    Google Scholar 

  90. http://www.multiplemyeloma.org/ Multiple Myeloma Research

    Google Scholar 

  91. http://www.ama-assn.org/ American Medical Association

    Google Scholar 

  92. http://courses.washington.edu/bonephys/opbis.html Bisphosphonates

    Google Scholar 

  93. http://www.cancerbackup.org.uk/
Treatments/Supportivetherapies/Bisphosphonates Cancer Backup

    Google Scholar 

  94. http://www.cochrane.org/reviews/en/index_list_b.html Cochrane Library

    Google Scholar 

  95. Convey AM. Management of malignant pleural effusions and ascites. J Support Oncol 2005;3:169–76

    Google Scholar 

  96. Nelson KA, Walsh D, Abdullah O et al. Common complications of advanced cancer. Semin Oncol 2000;27:34–44

    PubMed  CAS  Google Scholar 

  97. http://www.uic.edu/classes/pmpr/pmpr652/Final/
bressler/maligeffu.html University of Illinois Education

    Google Scholar 

  98. http://www.cancer.gov/cancertopics/pdq/
supportivecare/cardiopulmonary/HealthProfessional/page3 NCI

    Google Scholar 

  99. Alexandrakis MG, Passam FH, Kyriakou DS et al. Pleural effusions in hematologic malignancies. Chest 2004;125:1546–55

    PubMed  Google Scholar 

  100. Antony VB, Loddenkemper R, Astoul P et al. Management of malignant pleural effusions. Eur Respir J 2001;18:402–19

    PubMed  CAS  Google Scholar 

  101. Antunes G, Neville E, Duffy J et al. BTS guidelines for the management of malignant pleural effusions. Thorax 2003;58:29–38

    Google Scholar 

  102. Light RW. Pleural effusion. N Engl J Med 2002;346:1971–7

    PubMed  Google Scholar 

  103. Pollak JS. Malignant pleural effusions: treatment with tunneled long-term drainage catheters. Curr Opin Pulm Med 2002;8:302–7

    PubMed  Google Scholar 

  104. Rahman NM, Chapman SJ, Davies RJ. Pleural effusion: a structured approach to care. Br Med Bull 2005;72:31–47

    PubMed  Google Scholar 

  105. Tarn AC, Lapworth R. Biochemical analysis of pleural analysis of pleural fluid: what should we measure? Ann Clin Biochem 2001;38:311–22

    PubMed  CAS  Google Scholar 

  106. Tassi GF, Cardillo G, Marchetti GP et al. Diagnostic and therapeutical management of malignant pleural effusion. Ann Oncol 2006;17(suppl 2):ii11–2

    PubMed  Google Scholar 

  107. http://www.merck.com/mmpe/sec05/ch060/ch060d.html Merck Manual

    Google Scholar 

  108. http://www.meds.com/pdq/effusion_pro.html Medicine Online

    Google Scholar 

  109. http://www.emedicine.com/EMERG/topic462.htm Emedicine

    Google Scholar 

  110. http://www.emedicine.com/med/topic1843.htm Pleural Effusion, Emedicine

    Google Scholar 

  111. http://www.nlm.nih.gov/medlineplus/ency/article/000086.htm Medline Plus

    Google Scholar 

  112. Chen EP, Miller JI. Modern approaches and use of surgical treatment for pericardial disease. Curr Cardiol Rep 2002;41:4–6

    CAS  Google Scholar 

  113. Keefe DL. Cardiovascular emergencies in the cancer patient. Semin Oncol 2000;27:244–55

    PubMed  CAS  Google Scholar 

  114. Maher EA. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996;112:637–43

    PubMed  CAS  Google Scholar 

  115. Maisch B, Sererovic PM, Ristic AD et al. Guidelines on the diagnosis and management of effusions. Eur Soc Cardiol, 2004

    Google Scholar 

  116. Martinoni A, Cipolla CM, Civelli M et al. Intrapericardial treatment of neoplastic pericardial effusions. Herz 2000;25:787–93

    PubMed  CAS  Google Scholar 

  117. Retter AS. Pericardial disease in the oncology patient. Heart Dis 2002;4:387–91

    PubMed  Google Scholar 

  118. Shepherd FA. Malignant pericardial effusion. Curr Opin Oncol 1997;9:170–4

    PubMed  CAS  Google Scholar 

  119. http://www.emedicine.com/med/topic1786.htm Pericardial Effusion, e-medicine

    Google Scholar 

  120. http://www.nlm.nih.gov/medlineplus/ency/article/000194.htm Medline Plus

    Google Scholar 

  121. http://www.nci.nih.gov/cancertopics/pdq/supportivecare/
cardiopulmonary/HealthProfessional NCI PDQ

    Google Scholar 

  122. Becker G, Galandi D, Blum HE. Malignant ascites: Systematic review and guideline for treatment. Eur J Cancer 2006;42:589–97

    PubMed  Google Scholar 

  123. Jeffery J, Murphy MJ. Ascitic fluid analysis: the role of biochemistry and haematology. Hosp Med 2001;62:282–6

    PubMed  CAS  Google Scholar 

  124. Markmann M. Intraperitoneal chemotherapy. Semin Oncol 1991;18:248–54

    Google Scholar 

  125. McHutchinson JG. Differential diagnosis of ascites. Semin Liver Dis 1997;17:191–202

    Google Scholar 

  126. Parsons SL, Watson SA, Steele RJ. Malignant ascites. Br J Surg 1996;83:6–14

    PubMed  CAS  Google Scholar 

  127. Runyon BA. Care of patients with ascites. N Engl J Med 1994;330:337–42

    PubMed  CAS  Google Scholar 

  128. Smith EM, Jayson GC. The current and future management of malignant ascites. Clin Oncol 2003;15:59–72

    CAS  Google Scholar 

  129. http://www.cancerweb.ncl.ac.uk/cancernet/103862.html Malignant Ascites, Cancernet

    Google Scholar 

  130. http://www.surgicaloncology.com/psmreslt.htm Surgical Oncology

    Google Scholar 

  131. http://www.emedicine.com/med/topic173.htm Emedicine

    Google Scholar 

  132. American Association of Blood Banks, Association Bulletins #97/2 and #02-4

    Google Scholar 

  133. BCSH (British Committee for Standards in Hematology). Guidelines for the use of platelet transfusions. Br J Haematol 2003;122:10–23

    Google Scholar 

  134. Goodnough LT, Brecher ME, Kantner MH et al. Transfusion medicine. N Engl J Med 1999;340:438–47, 525–33

    Google Scholar 

  135. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007;370:415–26

    PubMed  Google Scholar 

  136. Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007;370:427–38

    PubMed  Google Scholar 

  137. Triulzi DJ. Blood Transfusion Therapy: A Physician’s Handbook, 7th edn. AABB Bookstore, 2002

    Google Scholar 

  138. Wandt H, Ehninger G, Gallmeier WM. New strategies for prophylactic platelet transfusion in patients with hematologic diseases. The Oncologist 2001;6:446–50

    PubMed  CAS  Google Scholar 

  139. http://www.aabb.org/ American Association of Blood Banks

    Google Scholar 

  140. http://www.bbts.org.uk/ British Blood Transfusion Society

    Google Scholar 

  141. http://www.ohsu.edu/pathology/transman/index.html Transfusion Manual

    Google Scholar 

  142. http://www.who.int/bloodsafety/en/ WHO Site on Blood Safety

    Google Scholar 

  143. Farrugia A, Poulis P. Intravenous immunoglobulin: regulatory perspectives on use and supply. Transfus Med 2001;11:63–74

    PubMed  CAS  Google Scholar 

  144. Hellstern P, Halbmayer WM, Köhler M et al. Prothrombin complex concentrates: indications, contraindications and risks. Thromb Res 1999;95:S3–6

    PubMed  CAS  Google Scholar 

  145. Key NS. Coagulation factor concentrates. Lancet 2007;370:439–48

    PubMed  CAS  Google Scholar 

  146. Staudinger T, Frass M, Rintelen C et al. Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients. Intensive Care Med 1999;25:1105–10

    PubMed  CAS  Google Scholar 

  147. http://www.med.unc.edu/isth International Society on Thrombosis and Haemostasis

    Google Scholar 

  148. Anger JT, Gilbert BR, Goldstein M. Cryopreservation of sperm: indications, methods and results. J Urol 2003;170:1079–84

    PubMed  Google Scholar 

  149. Crockin SL. Legal issues related to parenthood after cancer. J Natl Cancer Inst Monogr 2005;34:111–13

    PubMed  Google Scholar 

  150. Lee SJ, Schover LR, Partridge AH et al. ASCO recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917–31

    PubMed  Google Scholar 

  151. Orwig KE, Schlatt S. Cryopreservation and transplantation of spermatogonia and testicular tissue for the preservation of male fertility. J Natl Cancer Inst Monogr 2005;34:51–6

    PubMed  Google Scholar 

  152. Postovsky S, Lightman A, Aminpour D et al. Sperm cryopreservation in adolescents with newly diagnosed cancer. Med Pediatr Oncol 2003;40:355–9

    PubMed  Google Scholar 

  153. Puschek E, Philip PA, Jeyendran RS. Male fertility preservation and cancer treatment. Cancer Treat Rev 2004;30:173–80

    Google Scholar 

  154. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered ? Lancet Oncol 2005;6:209–18

    PubMed  Google Scholar 

  155. http://www.givf.com/ Genetics and IVF Institute

    Google Scholar 

  156. http://www.nci.nih.gov/cancertopics/pdq/supportivecare/
sexuality/HealthProfessional/page6 NCI PDQ

    Google Scholar 

  157. Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy. Curr Opin Obstet Gynecol 2005;17:21–6

    PubMed  Google Scholar 

  158. Lee SJ, Schover LR, Partridge AH et al. ASCO recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917–31

    PubMed  Google Scholar 

  159. Patrizio P, Butts S, Caplan A. Ovarian tissue preservation and future fertility: emerging technologies and ethical considerations. J Natl Cancer Inst Monogr 2005;34:107–10

    PubMed  Google Scholar 

  160. Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2004;82:933–8

    Google Scholar 

  161. Roberts JE, Oktay K. Fertility preservation: a comprehensive approach to the young woman with cancer. J Natl Cancer Inst Monogr 2005;34:57–9

    PubMed  Google Scholar 

  162. http://www.givf.com/ Genetics and IVF Institute

    Google Scholar 

  163. http://www.nci.nih.gov/cancertopics/pdq/supportivecare/
sexuality/HealthProfessional/page6 NCI PDQ

    Google Scholar 

  164. Basson R, Schultz WW. Sexual sequelae of general medical disorders. Lancet 2007;369:409–24

    PubMed  Google Scholar 

  165. Derogatis LR, Kourlesis SM. An approach to evaluation of sexual problems in the cancer patient. CA Cancer J Clin 1981;31:46–50

    PubMed  CAS  Google Scholar 

  166. Hollenbeck BK, Dunn RL, Wei JT et al. Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage breast cancer. Curr Urol Rep 2994;5:212–19

    Google Scholar 

  167. Kornblith AB, Ligibel J. Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol 2003;30:799–913

    PubMed  Google Scholar 

  168. Lue TF. Erectile dysfunction. N Engl J Med 2000;342:1802–13

    PubMed  CAS  Google Scholar 

  169. Wilmoth MC, Botchway P. Psychosexual implications of breast and gynecologic cancer. Cancer Invest 1999;17:631–6

    PubMed  CAS  Google Scholar 

  170. http://www.meb.uni-bonn.de/cancer.gov/CDR0000062859.html Cancernet

    Google Scholar 

  171. http://cancernet.nci.nih.gov/cancertopics/pdq/supportivecare Cancernet

    Google Scholar 

  172. http://www.cancerbackup.org.uk/info/sexuality.htm CancerBACKUP

    Google Scholar 

  173. Dimeo F, Stieglitz RD, Novelli-Fischer U et al. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999;85:2273–7

    PubMed  CAS  Google Scholar 

  174. Knols R, Aaronson NK, Uebelhart D et al. Physical exercise in cancer patients during and after medical treatment. J Clin Oncol 2005;23:3830–42

    PubMed  Google Scholar 

  175. McTiernan A. Physical activity after cancer: physiologic outcomes. Cancer Invest 2004;22:68–81

    PubMed  Google Scholar 

  176. Meyerhardt JA, Heseltine D, Niedzwiecki D et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer. J Clin Oncol 2006;24:3535–41

    PubMed  Google Scholar 

  177. Stevinson C, Lawlor DA, Fox KR. Exercise interventions for cancer patients. Cancer Causes Control 2004;15:1035–56

    PubMed  Google Scholar 

  178. http://www.apta.org Am Physical Therapy Assoc

    Google Scholar 

  179. Keefe DM, Schubert MM, Elting LS et al. Updated clinical practice guidelines for prevention and treatment of mucositis. Cancer 2007;109:820–31

    PubMed  CAS  Google Scholar 

  180. Stevenson J, Abernethy P A, Miller C, Currow DC. Managing comorbidities in patients at the end of life. BMJ 2004;329;909–12

    PubMed  Google Scholar 

  181. http://www.ons.org Oncology Nursing Society

    Google Scholar 

  182. http://www.harcourt-international.com/journals/ejon/ European Journal of Oncology Nursing

    Google Scholar 

  183. Faller H, Bülzebruck H. Coping and survival in lung cancer: a 10-year follow-up- Am J Psychiatry 2002;159:2105–7

    PubMed  Google Scholar 

  184. Fawzy FI, Fawzy NW. A structured psychoeducational intervention for cancer patients. Gen Hosp Psychiatry 1994;16:149–92

    PubMed  CAS  Google Scholar 

  185. Fritzsche K, Stein B, Herzog T et al. Psychosocial care of oncological in-patients. An empirical study of psychiatric and psychosomatic consultation services. Onkologie 1998;21:150–5

    Google Scholar 

  186. Greer S, Moorey S, Baruch JD, Watson M, Robertson BM, Mason A, Rowden L, Law MG, Bliss JM. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br Med J 1992;304:675–80

    CAS  Google Scholar 

  187. Jenkins V, Fallowfield L, Saul J. Information need of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001;84:48–51

    PubMed  CAS  Google Scholar 

  188. Kendall WS. Suicide and cancer: a gender-comparative study. Ann Oncol 2007;18:381–7

    Google Scholar 

  189. http://www.dapo-ev.de German Association of Psychosocial-oncology

    Google Scholar 

  190. http://www.ipos-society.org/ International Psychooncology Society

    Google Scholar 

  191. www.psycho-oncology.net International Directory of Psycho-oncology Programs

    Google Scholar 

  192. Cheville AL. Cancer rehabilitation. Semin Oncol 2005;32:219–24

    PubMed  Google Scholar 

  193. World Health Organization (WHO) 2001. International Classification of Functioning, Disability and Health (ICF). WHO Publication, Geneva

    Google Scholar 

  194. http://www.emedicine.com/pmr/topic226.htm emedicine

    Google Scholar 

  195. http://www.northeastrehab.com/Programs/oncology.htm Northeast Rehab Health Network

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Michael Daskalakis, Hartmut Bertz, Veronique Thierry, Claudia I. Müller, Antonia Müller, Gudrun Zürcher, Hans-Peter Zahradnik, Björn-Hans Rüter, Tanja Gölz & Alexander Wünsch

  2. Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Monika Engelhardt, Jürgen Heinz & Dietmar P. Berger

  3. Department of Translational Oncology, National Center for Tumor Diseases Heidelberg(NCT), Im Neuenheimer Feld 350, 69120, Heidelberg, Germany

    Karin Potthoff

  4. Comprehensive Cancer Center Freiburg, Tumorzentrum Ludwig Heilmeyer, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Elke Reinert & Hartmut Henß

  5. Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, 01307, Dresden, Germany

    Alexander Kiani

  6. Institute of Immunology, Serology and Transfusion Medicine, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany

    Albrecht Leo

  7. Johnson & Johnson, Turnhoutseweg 30b, 2340, Beerse, Belgium

    Eugen Leo

  8. Department of Urology, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Ulrich Wetterauer

  9. Central Physiotherapy, Department of Internal Medicine, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Ursula Blattmann

  10. Department of Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Katrin Heeskens

  11. Fachklinik f. Innere Medizin, Hematologie/Onkologie, Asklepios Klinik Triberg, Ludwigstrasse 1-2, 78098, Triberg, Germany

    Gerhard Adam & Christoph Zeller

Authors
  1. Michael Daskalakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hartmut Bertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Veronique Thierry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudia I. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Monika Engelhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Antonia Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gudrun Zürcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. U. Brunnmüler
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Karin Potthoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jürgen Heinz
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Elke Reinert
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hartmut Henß
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Dietmar P. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Alexander Kiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Albrecht Leo
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Eugen Leo
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. C. Keck
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Hans-Peter Zahradnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Ulrich Wetterauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. R. Schindler
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. S. Stobrawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. A. Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Ursula Blattmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Björn-Hans Rüter
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Katrin Heeskens
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Tanja Gölz
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. B. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. Alexander Wünsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Gerhard Adam
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. Christoph Zeller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Hematology and Oncology, University Medical Center, Hugstetter Str. 55, 79106, Freiburg, Germany

    Dietmar P. Berger , Monika Engelhardt  & Roland Mertelsmann ,  & 

  2. Tumorzentrum Ludwig-Heilmeyer, Comprehensive Cancer Center, University Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Hartmut Henß

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Daskalakis, M. et al. (2008). Supportive Treatment. In: Berger, D., Engelhardt, M., Henß, H., Mertelsmann, R. (eds) Concise Manual of Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73277-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-73277-8_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-73276-1

  • Online ISBN: 978-3-540-73277-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation